Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales
Novo Nordisk stock slumped Wednesday on its second-quarter earnings miss as sales of Wegovy and Ozempic both came in light. The post Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales appeared first on Investor's Business Daily.
Novo Nordisk stock slumped Wednesday on its second-quarter earnings miss as sales of Wegovy and Ozempic both came in light.
The post Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
